These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 28709658)
1. NgAgo-gDNA system efficiently suppresses hepatitis B virus replication through accelerating decay of pregenomic RNA. Wu Z; Tan S; Xu L; Gao L; Zhu H; Ma C; Liang X Antiviral Res; 2017 Sep; 145():20-23. PubMed ID: 28709658 [TBL] [Abstract][Full Text] [Related]
2. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis. Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800 [TBL] [Abstract][Full Text] [Related]
3. No evidence for genome editing in mouse zygotes and HEK293T human cell line using the DNA-guided Natronobacterium gregoryi Argonaute (NgAgo). Khin NC; Lowe JL; Jensen LM; Burgio G PLoS One; 2017; 12(6):e0178768. PubMed ID: 28609472 [TBL] [Abstract][Full Text] [Related]
4. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact. Malmström S; Larsson SB; Hannoun C; Lindh M PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677 [TBL] [Abstract][Full Text] [Related]
6. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo. Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes. Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Cleavage Site and Confirmation of the Effectiveness of NgAgo Gene Editing on RNA Targets. Qu J; Xie Y; Guo Z; Liu X; Jiang J; Chen T; Li K; Hu Z; Luo D Mol Biotechnol; 2021 Dec; 63(12):1183-1191. PubMed ID: 34302285 [TBL] [Abstract][Full Text] [Related]
9. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308 [TBL] [Abstract][Full Text] [Related]
10. Efficient manipulation of gene expression using Natronobacterium gregoryi Argonaute in zebrafish. Dong Z; Chen X; Zhuo R; Li Y; Zhou Z; Sun Y; Liu Y; Liu M BMC Biol; 2023 Apr; 21(1):95. PubMed ID: 37095525 [TBL] [Abstract][Full Text] [Related]
11. No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells. Javidi-Parsijani P; Niu G; Davis M; Lu P; Atala A; Lu B PLoS One; 2017; 12(5):e0177444. PubMed ID: 28494027 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 System with Dual gRNAs Synergically Inhibit Hepatitis B Virus Replication. Fei L; Sun S; Yang Q; Huang Y; Li Q; Tao S; Chen L Discov Med; 2024 Jun; 36(185):1169-1179. PubMed ID: 38926103 [TBL] [Abstract][Full Text] [Related]
13. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425 [TBL] [Abstract][Full Text] [Related]
14. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells. Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962 [TBL] [Abstract][Full Text] [Related]
15. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication. Zhang J; Zhang Y; Khanal S; Cao D; Zhao J; Dang X; Nguyen LNT; Schank M; Wu XY; Jiang Y; Ning S; Wang L; El Gazzar M; Moorman JP; Guo H; Yao ZQ J Med Virol; 2023 Jul; 95(7):e28952. PubMed ID: 37455550 [TBL] [Abstract][Full Text] [Related]
16. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle. Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770 [TBL] [Abstract][Full Text] [Related]
17. DNA-guided genome editing using the Natronobacterium gregoryi Argonaute. Gao F; Shen XZ; Jiang F; Wu Y; Han C Nat Biotechnol; 2016 Jul; 34(7):768-73. PubMed ID: 27136078 [TBL] [Abstract][Full Text] [Related]
18. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA. Sheraz M; Cheng J; Tang L; Chang J; Guo JT J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306 [TBL] [Abstract][Full Text] [Related]
19. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA]. Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080 [No Abstract] [Full Text] [Related]
20. The cooperative complex of Argonaute-2 and microRNA-146a regulates hepatitis B virus replication through flap endonuclease 1. Ji M; Mei X; Jing X; Xu X; Chen X; Pan W Life Sci; 2020 Sep; 257():118089. PubMed ID: 32659369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]